![](https://investorshub.advfn.com/uicon/138434.png?cb=1464725830)
Saturday, August 15, 2020 1:22:21 PM
"Further, the company plans to file a third EUA application for its GenViro! saliva based method, but this time will hold off on the application until the testing trials are complete and file the application along with the data."
https://backend.otcmarkets.com/otcapi/company/financial-report/254965/content
IMO, this application will never be filed because they will never complete any trials.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM